New heart pump device tested in emergency shock patients
NCT ID NCT07293923
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study is testing a new heart pump device (Magenta Elevate) in 10 people with cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. The device is inserted through a blood vessel to help the heart pump. Researchers are checking if it is safe and can quickly improve blood pressure and stability.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Magenta Elevate™ percutaneous left ventricular assist device (pLVAD) system
What this could lead to
If this device works well, it could offer a new way to temporarily support the heart in people with cardiogenic shock, helping stabilize them while they recover.
What could go wrong
This is a very early feasibility study with only 10 participants, so results may not apply to all patients. The device is new and could have unexpected complications or fail to improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Israeli-Georgian Medical Research Clinic Helsicore
RECRUITINGTbilisi, Georgia
Contact
-
Rambam Medical Center
RECRUITINGHaifa, Israel
Contact
-
Shamir Medical Center
RECRUITINGBe’er Ya‘aqov, Israel
Contact
-
Tbilisi Heart Center
RECRUITINGTbilisi, Georgia
Contact
-
Tel-Aviv Sourasky Medical Center
RECRUITINGTel Aviv, Israel
Contact